Xenon-129
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Children's Hospital Medical Center, Cincinnati
Overview
Xenon-129 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Xenon-129 clinical trials
Explore related
Medical disclaimer. This page summarizes research about Xenon-129 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.